Marketwatch Zydus Gets US Regulator’s Approval To Market Generic Epilepsy Drug Admin December 1, 2022 The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, Zydus said in a statement. NDTV Profit-Latest Share on Facebook Tweet it Pin it Share it Email